EMEA (Europe, Middle East and Africa) Insulin Market Report 2017

December 2017 | 102 pages | ID: E546979E470EN
QYResearch

Abstracts

In this report, the EMEA Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Insulin for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insulin market competition by top manufacturers/players, with Insulin sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novo Nordisk
• Sanofi
• Eli Lilly
• Bioton
• Dongbao
• Gan & Lee
• United Laboratories (TUL)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Short-acting
• Mid-acting
• Long-acting

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Home Usage

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Insulin Market Report 2017

1 INSULIN OVERVIEW

1.1 Product Overview and Scope of Insulin
1.2 Classification of Insulin
  1.2.1 EMEA Insulin Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Insulin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Short-acting
  1.2.4 Mid-acting
  1.2.5 Long-acting
1.3 EMEA Insulin Market by Application/End Users
  1.3.1 EMEA Insulin Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Usage
1.4 EMEA Insulin Market by Region
  1.4.1 EMEA Insulin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Insulin (2012-2022)
  1.5.1 EMEA Insulin Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Insulin Revenue and Growth Rate (2012-2022)

2 EMEA INSULIN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Insulin Market Competition by Players/Manufacturers
  2.1.1 EMEA Insulin Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Insulin Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Insulin Sale Price by Players (2012-2017)
2.2 EMEA Insulin (Volume and Value) by Type/Product Category
  2.2.1 EMEA Insulin Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Insulin Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Insulin Sale Price by Type (2012-2017)
2.3 EMEA Insulin (Volume) by Application
2.4 EMEA Insulin (Volume and Value) by Region
  2.4.1 EMEA Insulin Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Insulin Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Insulin Sales Price by Region (2012-2017)

3 EUROPE INSULIN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Insulin Sales and Value (2012-2017)
  3.1.1 Europe Insulin Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Insulin Revenue and Growth Rate (2012-2017)
3.2 Europe Insulin Sales and Market Share by Type
3.3 Europe Insulin Sales and Market Share by Application
3.4 Europe Insulin Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Insulin Sales Volume by Countries (2012-2017)
  3.4.2 Europe Insulin Revenue by Countries (2012-2017)
  3.4.3 Germany Insulin Sales and Growth Rate (2012-2017)
  3.4.4 France Insulin Sales and Growth Rate (2012-2017)
  3.4.5 UK Insulin Sales and Growth Rate (2012-2017)
  3.4.6 Russia Insulin Sales and Growth Rate (2012-2017)
  3.4.7 Italy Insulin Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Insulin Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INSULIN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Insulin Sales and Value (2012-2017)
  4.1.1 Middle East Insulin Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Insulin Revenue and Growth Rate (2012-2017)
4.2 Middle East Insulin Sales and Market Share by Type
4.3 Middle East Insulin Sales and Market Share by Application
4.4 Middle East Insulin Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Insulin Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Insulin Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Insulin Sales and Growth Rate (2012-2017)
  4.4.4 Israel Insulin Sales and Growth Rate (2012-2017)
  4.4.5 UAE Insulin Sales and Growth Rate (2012-2017)
  4.4.6 Iran Insulin Sales and Growth Rate (2012-2017)

5 AFRICA INSULIN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Insulin Sales and Value (2012-2017)
  5.1.1 Africa Insulin Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Insulin Revenue and Growth Rate (2012-2017)
5.2 Africa Insulin Sales and Market Share by Type
5.3 Africa Insulin Sales and Market Share by Application
5.4 Africa Insulin Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Insulin Sales Volume by Countries (2012-2017)
  5.4.2 Africa Insulin Revenue by Countries (2012-2017)
  5.4.3 South Africa Insulin Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Insulin Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Insulin Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Insulin Sales and Growth Rate (2012-2017)

6 EMEA INSULIN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Insulin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Insulin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Insulin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bioton
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Insulin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bioton Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dongbao
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Insulin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dongbao Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Gan & Lee
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Insulin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Gan & Lee Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 United Laboratories (TUL)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Insulin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 United Laboratories (TUL) Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 INSULIN MANUFACTURING COST ANALYSIS

7.1 Insulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INSULIN MARKET FORECAST (2017-2022)

11.1 EMEA Insulin Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Insulin Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Insulin Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Insulin Price and Trend Forecast (2017-2022)
11.2 EMEA Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Insulin Sales Forecast by Type (2017-2022)
11.7 EMEA Insulin Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Insulin
Figure EMEA Insulin Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Insulin Sales Volume Market Share by Type (Product Category) in 2016
Figure Short-acting Product Picture
Figure Mid-acting Product Picture
Figure Long-acting Product Picture
Figure EMEA Insulin Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Insulin by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Usage Examples
Table Key Downstream Customer in Home Usage
Figure EMEA Insulin Market Size (Million USD) by Region (2012-2022)
Figure Europe Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Insulin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Insulin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Insulin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Insulin Sales Volume and Growth Rate (2012-2022)
Figure EMEA Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Insulin Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Insulin Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Insulin Sales Share by Players (2012-2017)
Figure 2016 Insulin Sales Share by Players
Figure 2017 Insulin Sales Share by Players
Figure EMEA Insulin Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Insulin Revenue (Million USD) by Players (2012-2017)
Table EMEA Insulin Revenue Share by Players (2012-2017)
Table 2016 EMEA Insulin Revenue Share by Players
Table 2017 EMEA Insulin Revenue Share by Players
Table EMEA Insulin Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Insulin Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Insulin Sales Share by Type (2012-2017)
Figure Sales Market Share of Insulin by Type (2012-2017)
Figure EMEA Insulin Sales Market Share by Type (2012-2017)
Table EMEA Insulin Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insulin by Type in 2016
Table EMEA Insulin Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Insulin Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Insulin Sales Share by Application (2012-2017)
Figure Sales Market Share of Insulin by Application (2012-2017)
Figure EMEA Insulin Sales Market Share by Application in 2016
Table EMEA Insulin Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Insulin Sales Share by Region (2012-2017)
Figure Sales Market Share of Insulin by Region (2012-2017)
Figure EMEA Insulin Sales Market Share in 2016
Table EMEA Insulin Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Insulin Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Insulin by Region (2012-2017)
Figure EMEA Insulin Revenue Market Share Regions in 2016
Table EMEA Insulin Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Insulin Revenue and Growth Rate (2012-2017)
Table Europe Insulin Sales (K Doses) by Type (2012-2017)
Table Europe Insulin Market Share by Type (2012-2017)
Figure Europe Insulin Market Share by Type in 2016
Table Europe Insulin Sales (K Doses) by Application (2012-2017)
Table Europe Insulin Market Share by Application (2012-2017)
Figure Europe Insulin Market Share by Application in 2016
Table Europe Insulin Sales (K Doses) by Countries (2012-2017)
Table Europe Insulin Sales Market Share by Countries (2012-2017)
Figure Europe Insulin Sales Market Share by Countries (2012-2017)
Figure Europe Insulin Sales Market Share by Countries in 2016
Table Europe Insulin Revenue (Million USD) by Countries (2012-2017)
Table Europe Insulin Revenue Market Share by Countries (2012-2017)
Figure Europe Insulin Revenue Market Share by Countries (2012-2017)
Figure Europe Insulin Revenue Market Share by Countries in 2016
Figure Germany Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure France Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Insulin Sales (K Doses) by Type (2012-2017)
Table Middle East Insulin Market Share by Type (2012-2017)
Figure Middle East Insulin Market Share by Type (2012-2017)
Table Middle East Insulin Sales (K Doses) by Applications (2012-2017)
Table Middle East Insulin Market Share by Applications (2012-2017)
Figure Middle East Insulin Sales Market Share by Application in 2016
Table Middle East Insulin Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Insulin Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Insulin Sales Volume Market Share by Countries in 2016
Table Middle East Insulin Revenue (Million USD) by Countries (2012-2017)
Table Middle East Insulin Revenue Market Share by Countries (2012-2017)
Figure Middle East Insulin Revenue Market Share by Countries (2012-2017)
Figure Middle East Insulin Revenue Market Share by Countries in 2016
Figure Saudi Arabia Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Insulin Sales (K Doses) by Type (2012-2017)
Table Africa Insulin Sales Market Share by Type (2012-2017)
Figure Africa Insulin Sales Market Share by Type (2012-2017)
Figure Africa Insulin Sales Market Share by Type in 2016
Table Africa Insulin Sales (K Doses) by Application (2012-2017)
Table Africa Insulin Sales Market Share by Application (2012-2017)
Figure Africa Insulin Sales Market Share by Application (2012-2017)
Table Africa Insulin Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Insulin Sales Market Share by Countries (2012-2017)
Figure Africa Insulin Sales Market Share by Countries (2012-2017)
Figure Africa Insulin Sales Market Share by Countries in 2016
Table Africa Insulin Revenue (Million USD) by Countries (2012-2017)
Table Africa Insulin Revenue Market Share by Countries (2012-2017)
Figure Africa Insulin Revenue Market Share by Countries (2012-2017)
Figure Africa Insulin Revenue Market Share by Countries in 2016
Figure South Africa Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Insulin Sales (K Doses) and Growth Rate (2012-2017)
Table Novo Nordisk Insulin Basic Information List
Table Novo Nordisk Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Novo Nordisk Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Novo Nordisk Insulin Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Insulin Revenue Market Share in EMEA (2012-2017)
Table Sanofi Insulin Basic Information List
Table Sanofi Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Sanofi Insulin Sales Market Share in EMEA (2012-2017)
Figure Sanofi Insulin Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Insulin Basic Information List
Table Eli Lilly Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Eli Lilly Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Eli Lilly Insulin Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Insulin Revenue Market Share in EMEA (2012-2017)
Table Bioton Insulin Basic Information List
Table Bioton Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bioton Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Bioton Insulin Sales Market Share in EMEA (2012-2017)
Figure Bioton Insulin Revenue Market Share in EMEA (2012-2017)
Table Dongbao Insulin Basic Information List
Table Dongbao Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Dongbao Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Dongbao Insulin Sales Market Share in EMEA (2012-2017)
Figure Dongbao Insulin Revenue Market Share in EMEA (2012-2017)
Table Gan & Lee Insulin Basic Information List
Table Gan & Lee Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Gan & Lee Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure Gan & Lee Insulin Sales Market Share in EMEA (2012-2017)
Figure Gan & Lee Insulin Revenue Market Share in EMEA (2012-2017)
Table United Laboratories (TUL) Insulin Basic Information List
Table United Laboratories (TUL) Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure United Laboratories (TUL) Insulin Sales (K Doses) and Growth Rate (2012-2017)
Figure United Laboratories (TUL) Insulin Sales Market Share in EMEA (2012-2017)
Figure United Laboratories (TUL) Insulin Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin
Figure Manufacturing Process Analysis of Insulin
Figure Insulin Industrial Chain Analysis
Table Raw Materials Sources of Insulin Major Manufacturers in 2016
Table Major Buyers of Insulin
Table Distributors/Traders List
Figure EMEA Insulin Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Insulin Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Insulin Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Insulin Sales Market Share Forecast by Region (2017-2022)
Table EMEA Insulin Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Insulin Revenue Market Share Forecast by Region (2017-2022)
Table Europe Insulin Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Insulin Sales Market Share Forecast by Countries (2017-2022)
Table Europe Insulin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Insulin Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Insulin Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Insulin Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Insulin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Insulin Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Insulin Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Insulin Sales Market Share Forecast by Countries (2017-2022)
Table Africa Insulin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Insulin Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Insulin Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Insulin Sales Market Share Forecast by Type (2017-2022)
Table EMEA Insulin Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Insulin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources